Targeting focal adhesion kinase boosts immune response in KRAS/LKB1 co-mutated lung adenocarcinoma via remodeling the tumor microenvironment

Targeting focal adhesion kinase boosts immune response in KRAS/LKB1 co-mutated lung adenocarcinoma via remodeling the tumor microenvironment

Abstract Background KRAS mutation is one of the most common oncogenic drivers in NSCLC, however, the response to immunotherapy is heterogeneous owing to the distinct co-occurring genomic alterations. KRAS/LKB1 co-mutated lung adenocarcinoma displays poor response to PD-1 blockade whereas the mechani...

Full description

Bibliographic Details
Main Authors: Meng Qiao, Fei Zhou, Xinyu Liu, Tao Jiang, Haowei Wang, Xuefei Li, Chao Zhao, Lei Cheng, Xiaoxia Chen, Shengxiang Ren, Zaiqi Wang, Caicun Zhou
Format: Article
Language:English
Published: BMC 2024-01-01
Series:Experimental Hematology & Oncology
Subjects:
Focal adhesion kinase
KRAS
LKB1
Drug resistance
Tumor microenvironment
Online Access:https://doi.org/10.1186/s40164-023-00471-6

Internet

https://doi.org/10.1186/s40164-023-00471-6

Similar Items